首页> 外文期刊>RSC Advances >Shell cross-linked polyethylenimine-modified micelles for temperature-triggered drug release and gene delivery
【24h】

Shell cross-linked polyethylenimine-modified micelles for temperature-triggered drug release and gene delivery

机译:壳交联聚乙烯亚胺修饰的胶束,用于温度触发的药物释放和基因传递

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Stimuli-responsiveness is an important characteristic of nanocarriers that can deliver therapeutic molecules in a controlled and on-demand manner. In particular, temperature-responsive micelles have recently gained increasing attention for use in diverse therapeutic areas, including hyperthermia therapy. Herein, we developed novel shell cross-linked Pluronic F127 (PF127) polymers with branched polyethylenimine (PEI), called FPEI, for temperature-triggered drug delivery and gene transfection. The successful synthesis of FPEI copolymers was confirmed by Fourier-transform infrared spectroscopy, with the weight percent of PEI in the FPEI copolymers being 7.5%. The critical micelle concentration of FPEI and PF127 copolymers was shown to be 0.013 and 0.03 mg ml(-1) at room temperature, respectively. When Nile Red (NR), used as a hydrophobic model drug, was loaded into FPEI copolymers, the appropriate concentration of NR was 3 and 5 mg ml(-1) in 5 and 10 mg ml(-1) of FPEI, respectively. Interestingly, the loading capacity of FPEI increased with an increase in the micelle concentration. With increasing temperature, the NR release from the micelle increased, while the micelle radii of FPEI, NR-loaded FPEI, and NR-loaded FPEI-DNA decreased. The DNA binding ability of FPEI copolymers increased with an increase in the N/P ratio. FPEI cytotoxicity in HeLa cells showed a similar tendency, when equivalent PEI amount in FPEI was treated. While further in-depth studies remain as to the in vitro and in vivo biological functions, the FPEI system demonstrated well temperature-triggered NR release into HeLa cells, along with sufficient transfection of plasmid green fluorescence protein, which suggested potential usefulness in temperature-responsive therapy.
机译:刺激反应性是纳米载体的重要特征,其可以以受控和按需方式递送治疗性分子。特别地,温度响应性胶束最近在包括高温疗法在内的各种治疗领域中的使用中引起了越来越多的关注。在这里,我们开发了新型的壳交联的Pluronic F127(PF127)聚合物与支链聚乙烯亚胺(PEI),称为FPEI,用于温度触发的药物传递和基因转染。 FPEI共聚物的成功合成通过傅里叶变换红外光谱法得到证实,FPEI共聚物中PEI的重量百分比为7.5%。在室温下,FPEI和PF127共聚物的临界胶束浓度分别为0.013和0.03 mg ml(-1)。将用作疏水性模型药物的尼罗红(NR)装入FPEI共聚物中时,在5和10 mg ml(-1)的FPEI中,NR的适当浓度分别为3和5 mg ml(-1)。有趣的是,FPEI的负载能力随着胶束浓度的增加而增加。随着温度的升高,从胶束释放的NR增加,而FPEI,载有NR的FPEI和载有NR的FPEI-DNA的胶束半径减小。 FPEI共聚物的DNA结合能力随N / P比的增加而增加。当处理FPEI中等效的PEI量时,HeLa细胞中的FPEI细胞毒性显示出相似的趋势。尽管还需要进一步深入研究体外和体内生物学功能,但FPEI系统证明了温度触发的NR释放到HeLa细胞中的能力很好,并且质粒绿色荧光蛋白已被充分转染,这表明在温度响应方面具有潜在的用途。治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号